Cheryl Ackert-Bicknell
Concepts (367)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteoporosis | 15 | 2024 | 244 | 3.450 |
Why?
| | Bone Density | 31 | 2025 | 495 | 3.110 |
Why?
| | Bone and Bones | 14 | 2023 | 317 | 1.940 |
Why?
| | Quantitative Trait Loci | 20 | 2025 | 364 | 1.830 |
Why?
| | Genome-Wide Association Study | 21 | 2025 | 1406 | 1.800 |
Why?
| | Osteoblasts | 15 | 2025 | 135 | 1.160 |
Why?
| | Zebrafish | 5 | 2024 | 504 | 0.990 |
Why?
| | Genetic Variation | 8 | 2019 | 1000 | 0.850 |
Why?
| | Femur | 10 | 2018 | 260 | 0.810 |
Why?
| | Chromosome Mapping | 10 | 2019 | 504 | 0.790 |
Why?
| | Musculoskeletal Diseases | 2 | 2024 | 84 | 0.780 |
Why?
| | Intervertebral Disc | 1 | 2023 | 37 | 0.760 |
Why?
| | Intervertebral Disc Degeneration | 1 | 2023 | 34 | 0.760 |
Why?
| | Intervertebral Disc Displacement | 1 | 2023 | 41 | 0.760 |
Why?
| | Mice | 55 | 2024 | 18109 | 0.760 |
Why?
| | Animals | 66 | 2024 | 37749 | 0.640 |
Why?
| | Osteoporotic Fractures | 2 | 2022 | 61 | 0.620 |
Why?
| | Spine | 2 | 2018 | 180 | 0.600 |
Why?
| | Genome | 3 | 2019 | 303 | 0.600 |
Why?
| | Insulin-Like Growth Factor I | 9 | 2008 | 325 | 0.580 |
Why?
| | Fractures, Bone | 4 | 2022 | 406 | 0.580 |
Why?
| | Fracture Healing | 2 | 2016 | 84 | 0.570 |
Why?
| | Skeleton | 1 | 2016 | 6 | 0.500 |
Why?
| | Mice, Inbred C57BL | 16 | 2020 | 5909 | 0.500 |
Why?
| | Polymorphism, Single Nucleotide | 17 | 2021 | 2135 | 0.500 |
Why?
| | Alternative Splicing | 1 | 2018 | 232 | 0.490 |
Why?
| | PPAR gamma | 5 | 2010 | 181 | 0.490 |
Why?
| | Phenotype | 19 | 2024 | 3177 | 0.490 |
Why?
| | Laboratory Animal Science | 1 | 2015 | 4 | 0.470 |
Why?
| | Diphosphonates | 1 | 2016 | 69 | 0.460 |
Why?
| | Bone Density Conservation Agents | 1 | 2016 | 83 | 0.460 |
Why?
| | CRISPR-Cas Systems | 3 | 2025 | 152 | 0.450 |
Why?
| | Gene-Environment Interaction | 2 | 2013 | 187 | 0.450 |
Why?
| | Lipoproteins, HDL | 2 | 2013 | 78 | 0.400 |
Why?
| | Disease Models, Animal | 8 | 2024 | 4421 | 0.390 |
Why?
| | Body Composition | 6 | 2010 | 703 | 0.380 |
Why?
| | GATA Transcription Factors | 1 | 2012 | 7 | 0.370 |
Why?
| | Aging | 5 | 2021 | 1924 | 0.360 |
Why?
| | Hip | 1 | 2012 | 57 | 0.360 |
Why?
| | Cholesterol, HDL | 1 | 2012 | 196 | 0.350 |
Why?
| | Mice, Inbred Strains | 9 | 2015 | 412 | 0.340 |
Why?
| | Mice, Inbred C3H | 9 | 2010 | 270 | 0.340 |
Why?
| | Genetic Predisposition to Disease | 7 | 2022 | 2375 | 0.330 |
Why?
| | Thiazolidinediones | 2 | 2008 | 138 | 0.330 |
Why?
| | Chromosome Inversion | 2 | 2007 | 18 | 0.330 |
Why?
| | DNA-Binding Proteins | 3 | 2020 | 1485 | 0.330 |
Why?
| | Dietary Fats | 2 | 2011 | 300 | 0.320 |
Why?
| | Transcription Factors | 4 | 2023 | 1712 | 0.320 |
Why?
| | Gene Regulatory Networks | 3 | 2021 | 313 | 0.320 |
Why?
| | Osteoarthritis | 2 | 2025 | 199 | 0.310 |
Why?
| | Crosses, Genetic | 6 | 2012 | 133 | 0.310 |
Why?
| | Carrier Proteins | 5 | 2017 | 748 | 0.290 |
Why?
| | Gene Expression Regulation | 9 | 2020 | 2608 | 0.270 |
Why?
| | Genetic Association Studies | 3 | 2016 | 375 | 0.260 |
Why?
| | Chromosomes, Mammalian | 4 | 2012 | 28 | 0.260 |
Why?
| | Osteogenesis | 4 | 2021 | 199 | 0.260 |
Why?
| | Humans | 40 | 2025 | 141754 | 0.250 |
Why?
| | Cell Differentiation | 6 | 2021 | 2006 | 0.250 |
Why?
| | Mice, Knockout | 9 | 2020 | 3071 | 0.230 |
Why?
| | Genetic Pleiotropy | 2 | 2017 | 31 | 0.220 |
Why?
| | Pseudarthrosis | 1 | 2024 | 14 | 0.220 |
Why?
| | Diskectomy | 1 | 2024 | 25 | 0.220 |
Why?
| | Meta-Analysis as Topic | 2 | 2017 | 185 | 0.220 |
Why?
| | Synovial Membrane | 1 | 2025 | 121 | 0.220 |
Why?
| | Lipoproteins, LDL | 1 | 2024 | 113 | 0.220 |
Why?
| | Ankle Joint | 1 | 2025 | 115 | 0.210 |
Why?
| | Calcification, Physiologic | 2 | 2021 | 34 | 0.210 |
Why?
| | Bone Diseases | 2 | 2015 | 66 | 0.210 |
Why?
| | X-Ray Microtomography | 4 | 2018 | 99 | 0.210 |
Why?
| | Allelic Imbalance | 1 | 2023 | 9 | 0.210 |
Why?
| | Adipose Tissue | 2 | 2007 | 647 | 0.200 |
Why?
| | Sarcopenia | 2 | 2024 | 82 | 0.200 |
Why?
| | Longevity | 2 | 2015 | 175 | 0.200 |
Why?
| | Cervical Vertebrae | 1 | 2024 | 146 | 0.200 |
Why?
| | Organ Size | 4 | 2017 | 481 | 0.190 |
Why?
| | Craniosynostoses | 1 | 2023 | 58 | 0.190 |
Why?
| | Femoracetabular Impingement | 1 | 2022 | 35 | 0.190 |
Why?
| | Behavior, Animal | 2 | 2016 | 516 | 0.190 |
Why?
| | Osteoarthritis, Hip | 1 | 2022 | 48 | 0.190 |
Why?
| | Exons | 2 | 2018 | 353 | 0.190 |
Why?
| | HMGB1 Protein | 1 | 2022 | 50 | 0.180 |
Why?
| | Biology | 1 | 2023 | 92 | 0.180 |
Why?
| | Mammals | 1 | 2023 | 287 | 0.180 |
Why?
| | Zebrafish Proteins | 1 | 2024 | 292 | 0.180 |
Why?
| | Skull | 3 | 2023 | 151 | 0.180 |
Why?
| | Cell Culture Techniques | 2 | 2022 | 368 | 0.180 |
Why?
| | Regenerative Medicine | 1 | 2022 | 52 | 0.180 |
Why?
| | Musculoskeletal System | 1 | 2022 | 49 | 0.180 |
Why?
| | Spinal Fusion | 1 | 2024 | 259 | 0.180 |
Why?
| | Transcriptome | 6 | 2025 | 1014 | 0.170 |
Why?
| | Genotype | 5 | 2018 | 1866 | 0.170 |
Why?
| | Erythropoietin | 1 | 2022 | 98 | 0.170 |
Why?
| | Bone Marrow | 2 | 2015 | 302 | 0.170 |
Why?
| | Anemia | 1 | 2022 | 177 | 0.170 |
Why?
| | Antibody-Producing Cells | 1 | 2020 | 30 | 0.170 |
Why?
| | Muscle Weakness | 1 | 2021 | 93 | 0.160 |
Why?
| | Male | 28 | 2025 | 70179 | 0.160 |
Why?
| | Female | 35 | 2025 | 75943 | 0.160 |
Why?
| | Adipogenesis | 2 | 2010 | 57 | 0.160 |
Why?
| | Cell Separation | 1 | 2021 | 317 | 0.160 |
Why?
| | Antibodies, Bacterial | 1 | 2020 | 146 | 0.150 |
Why?
| | Computational Biology | 2 | 2021 | 664 | 0.150 |
Why?
| | Tetraspanins | 1 | 2019 | 19 | 0.150 |
Why?
| | Cartilage, Articular | 1 | 2022 | 331 | 0.150 |
Why?
| | Untranslated Regions | 1 | 2018 | 3 | 0.150 |
Why?
| | Promoter Regions, Genetic | 2 | 2018 | 1243 | 0.140 |
Why?
| | RAW 264.7 Cells | 1 | 2018 | 49 | 0.140 |
Why?
| | Information Management | 1 | 2018 | 17 | 0.140 |
Why?
| | Osteomyelitis | 1 | 2020 | 143 | 0.140 |
Why?
| | Sex Characteristics | 2 | 2018 | 792 | 0.140 |
Why?
| | Musculoskeletal Development | 1 | 2017 | 2 | 0.140 |
Why?
| | Cell Line | 5 | 2018 | 2887 | 0.140 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 1 | 2017 | 56 | 0.130 |
Why?
| | Genetic Markers | 2 | 2016 | 343 | 0.130 |
Why?
| | Calcaneus | 1 | 2017 | 30 | 0.130 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2019 | 204 | 0.130 |
Why?
| | Low Density Lipoprotein Receptor-Related Protein-5 | 1 | 2017 | 8 | 0.130 |
Why?
| | Quantitative Trait, Heritable | 2 | 2018 | 124 | 0.130 |
Why?
| | Pelvic Bones | 1 | 2019 | 129 | 0.130 |
Why?
| | Receptor, EphB2 | 1 | 2016 | 4 | 0.130 |
Why?
| | Excitatory Amino Acid Transporter 1 | 1 | 2016 | 6 | 0.130 |
Why?
| | Species Specificity | 5 | 2014 | 583 | 0.130 |
Why?
| | Wnt Proteins | 2 | 2015 | 136 | 0.130 |
Why?
| | Nuclear Proteins | 3 | 2011 | 719 | 0.130 |
Why?
| | Animals, Outbred Strains | 1 | 2016 | 5 | 0.130 |
Why?
| | Leukocytes | 1 | 2018 | 309 | 0.130 |
Why?
| | Glycoproteins | 3 | 2003 | 358 | 0.130 |
Why?
| | Histological Techniques | 1 | 2016 | 40 | 0.120 |
Why?
| | Retinal Vessels | 1 | 2017 | 75 | 0.120 |
Why?
| | Minerals | 1 | 2016 | 44 | 0.120 |
Why?
| | Mutagenesis | 1 | 2017 | 182 | 0.120 |
Why?
| | Staphylococcus aureus | 1 | 2020 | 437 | 0.120 |
Why?
| | Databases, Genetic | 2 | 2014 | 243 | 0.120 |
Why?
| | Immunoglobulin G | 1 | 2020 | 900 | 0.120 |
Why?
| | Spinal Fractures | 1 | 2016 | 74 | 0.120 |
Why?
| | Program Development | 1 | 2018 | 368 | 0.120 |
Why?
| | Sepsis | 1 | 2022 | 621 | 0.120 |
Why?
| | Staphylococcal Infections | 1 | 2020 | 392 | 0.120 |
Why?
| | Rodent Diseases | 1 | 2015 | 28 | 0.120 |
Why?
| | Animal Structures | 1 | 2015 | 10 | 0.120 |
Why?
| | Stem Cells | 2 | 2022 | 603 | 0.120 |
Why?
| | Bone Resorption | 1 | 2016 | 84 | 0.120 |
Why?
| | Haplotypes | 3 | 2012 | 499 | 0.110 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2021 | 876 | 0.110 |
Why?
| | Fracture Fixation, Intramedullary | 1 | 2015 | 55 | 0.110 |
Why?
| | Linkage Disequilibrium | 3 | 2021 | 255 | 0.110 |
Why?
| | Gene Expression Profiling | 4 | 2017 | 1771 | 0.110 |
Why?
| | Rats | 1 | 2023 | 5637 | 0.110 |
Why?
| | Face | 1 | 2015 | 175 | 0.110 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2014 | 66 | 0.110 |
Why?
| | Urination | 1 | 2014 | 48 | 0.100 |
Why?
| | Mice, Transgenic | 3 | 2015 | 2184 | 0.100 |
Why?
| | Urodynamics | 1 | 2014 | 49 | 0.100 |
Why?
| | Inbreeding | 2 | 2011 | 20 | 0.100 |
Why?
| | Transcription, Genetic | 4 | 2020 | 1487 | 0.100 |
Why?
| | Chronic Kidney Disease-Mineral and Bone Disorder | 1 | 2013 | 14 | 0.100 |
Why?
| | Animals, Newborn | 4 | 2021 | 870 | 0.100 |
Why?
| | Genome, Human | 1 | 2015 | 421 | 0.100 |
Why?
| | Lower Urinary Tract Symptoms | 1 | 2014 | 61 | 0.100 |
Why?
| | Actins | 2 | 2024 | 424 | 0.100 |
Why?
| | Genomics | 3 | 2015 | 815 | 0.100 |
Why?
| | Ovariectomy | 2 | 2011 | 158 | 0.100 |
Why?
| | Adipocytes | 3 | 2010 | 227 | 0.090 |
Why?
| | Cohort Studies | 4 | 2024 | 5815 | 0.090 |
Why?
| | Sequence Analysis, DNA | 3 | 2015 | 825 | 0.090 |
Why?
| | Bone Marrow Cells | 4 | 2010 | 327 | 0.090 |
Why?
| | Postoperative Complications | 1 | 2024 | 2821 | 0.090 |
Why?
| | Lod Score | 1 | 2012 | 64 | 0.090 |
Why?
| | Databases, Factual | 1 | 2018 | 1448 | 0.090 |
Why?
| | RNA Editing | 1 | 2012 | 26 | 0.090 |
Why?
| | Stromal Cells | 4 | 2006 | 117 | 0.090 |
Why?
| | Adipose Tissue, White | 1 | 2012 | 43 | 0.090 |
Why?
| | Liver | 6 | 2012 | 1820 | 0.090 |
Why?
| | Homeodomain Proteins | 1 | 2015 | 515 | 0.090 |
Why?
| | Environment | 1 | 2013 | 342 | 0.090 |
Why?
| | 3' Untranslated Regions | 1 | 2012 | 149 | 0.090 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 2 | 2003 | 209 | 0.090 |
Why?
| | Inflammation | 2 | 2022 | 2902 | 0.080 |
Why?
| | Myogenic Regulatory Factors | 1 | 2010 | 55 | 0.080 |
Why?
| | MEF2 Transcription Factors | 1 | 2010 | 59 | 0.080 |
Why?
| | Membrane Glycoproteins | 2 | 2003 | 502 | 0.080 |
Why?
| | Reproducibility of Results | 3 | 2019 | 3356 | 0.080 |
Why?
| | Gastrointestinal Microbiome | 1 | 2018 | 730 | 0.080 |
Why?
| | Severity of Illness Index | 1 | 2018 | 2903 | 0.080 |
Why?
| | Sequence Analysis, RNA | 2 | 2022 | 450 | 0.080 |
Why?
| | Estrogens | 1 | 2012 | 368 | 0.070 |
Why?
| | Bone Development | 2 | 2014 | 54 | 0.070 |
Why?
| | Research Design | 1 | 2015 | 1146 | 0.070 |
Why?
| | Circadian Rhythm | 2 | 2010 | 515 | 0.070 |
Why?
| | Mice, Inbred DBA | 1 | 2008 | 200 | 0.070 |
Why?
| | Repressor Proteins | 1 | 2012 | 430 | 0.070 |
Why?
| | Gene Expression | 4 | 2019 | 1492 | 0.070 |
Why?
| | Aged | 6 | 2025 | 24746 | 0.070 |
Why?
| | RNA, Messenger | 7 | 2019 | 2828 | 0.070 |
Why?
| | Alleles | 2 | 2008 | 891 | 0.070 |
Why?
| | Models, Animal | 2 | 2014 | 396 | 0.070 |
Why?
| | Europe | 2 | 2021 | 411 | 0.070 |
Why?
| | Somatomedins | 1 | 2006 | 28 | 0.060 |
Why?
| | Molecular Sequence Annotation | 2 | 2017 | 95 | 0.060 |
Why?
| | Cells, Cultured | 4 | 2020 | 4212 | 0.060 |
Why?
| | Muscle, Skeletal | 3 | 2024 | 1757 | 0.060 |
Why?
| | Mutation | 1 | 2017 | 4015 | 0.060 |
Why?
| | Bone Remodeling | 1 | 2006 | 77 | 0.060 |
Why?
| | MicroRNAs | 1 | 2012 | 692 | 0.060 |
Why?
| | Keratins | 1 | 2006 | 173 | 0.060 |
Why?
| | Case-Control Studies | 2 | 2025 | 3597 | 0.060 |
Why?
| | Myogenic Regulatory Factor 5 | 1 | 2024 | 6 | 0.060 |
Why?
| | Mammary Glands, Animal | 1 | 2006 | 131 | 0.060 |
Why?
| | MyoD Protein | 1 | 2024 | 33 | 0.060 |
Why?
| | Morphogenesis | 1 | 2006 | 171 | 0.060 |
Why?
| | Fish Oils | 1 | 2024 | 26 | 0.060 |
Why?
| | Obesity | 1 | 2018 | 3008 | 0.060 |
Why?
| | Gene Knockout Techniques | 1 | 2024 | 117 | 0.050 |
Why?
| | Muscular Diseases | 1 | 2024 | 113 | 0.050 |
Why?
| | Granulosa Cell Tumor | 1 | 2003 | 6 | 0.050 |
Why?
| | Muscle Development | 1 | 2024 | 114 | 0.050 |
Why?
| | X Chromosome | 1 | 2003 | 55 | 0.050 |
Why?
| | Genetic Diseases, X-Linked | 1 | 2003 | 24 | 0.050 |
Why?
| | Larva | 1 | 2024 | 238 | 0.050 |
Why?
| | Adiposity | 1 | 2008 | 521 | 0.050 |
Why?
| | Transcription Initiation Site | 1 | 2023 | 43 | 0.050 |
Why?
| | Middle Aged | 5 | 2025 | 34647 | 0.050 |
Why?
| | Oncogenes | 1 | 2003 | 118 | 0.050 |
Why?
| | Uncertainty | 1 | 2023 | 139 | 0.050 |
Why?
| | Polymorphism, Genetic | 1 | 2005 | 625 | 0.050 |
Why?
| | Osteoclasts | 2 | 2017 | 51 | 0.050 |
Why?
| | Single-Cell Analysis | 1 | 2025 | 338 | 0.050 |
Why?
| | Lipids | 1 | 2007 | 690 | 0.050 |
Why?
| | Receptors, Erythropoietin | 1 | 2022 | 20 | 0.050 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2013 | 987 | 0.050 |
Why?
| | Erythropoiesis | 1 | 2022 | 56 | 0.050 |
Why?
| | Protein Isoforms | 1 | 2023 | 398 | 0.040 |
Why?
| | Body Weight | 3 | 2017 | 997 | 0.040 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2024 | 439 | 0.040 |
Why?
| | Gene Ontology | 1 | 2021 | 53 | 0.040 |
Why?
| | Growth Differentiation Factor 5 | 1 | 2021 | 3 | 0.040 |
Why?
| | Bone Matrix | 1 | 2021 | 6 | 0.040 |
Why?
| | HLA-DQ alpha-Chains | 1 | 2021 | 16 | 0.040 |
Why?
| | Lipid Metabolism | 1 | 2024 | 528 | 0.040 |
Why?
| | Hip Joint | 1 | 2022 | 175 | 0.040 |
Why?
| | Adult | 5 | 2025 | 39391 | 0.040 |
Why?
| | Clinical Protocols | 1 | 2022 | 273 | 0.040 |
Why?
| | Gene Frequency | 2 | 2015 | 494 | 0.040 |
Why?
| | Growth Hormone | 3 | 2006 | 102 | 0.040 |
Why?
| | Wnt4 Protein | 1 | 2020 | 20 | 0.040 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2024 | 454 | 0.040 |
Why?
| | Cortical Bone | 1 | 2019 | 19 | 0.040 |
Why?
| | Hypoglycemic Agents | 1 | 2008 | 1374 | 0.040 |
Why?
| | Nitric Oxide | 1 | 2003 | 900 | 0.040 |
Why?
| | Calcium | 1 | 2024 | 1192 | 0.040 |
Why?
| | Bifidobacterium longum | 1 | 2018 | 5 | 0.040 |
Why?
| | ROC Curve | 1 | 2020 | 590 | 0.040 |
Why?
| | Prospective Studies | 2 | 2025 | 7777 | 0.040 |
Why?
| | Hip Fractures | 1 | 2019 | 86 | 0.030 |
Why?
| | Glypicans | 1 | 2017 | 11 | 0.030 |
Why?
| | Oligosaccharides | 1 | 2018 | 59 | 0.030 |
Why?
| | Muscle Strength | 1 | 2021 | 329 | 0.030 |
Why?
| | Tissue Engineering | 1 | 2022 | 429 | 0.030 |
Why?
| | Osteochondrodysplasias | 1 | 2017 | 20 | 0.030 |
Why?
| | Osteocytes | 1 | 2017 | 30 | 0.030 |
Why?
| | Ovarian Neoplasms | 1 | 2003 | 581 | 0.030 |
Why?
| | Electroretinography | 1 | 2017 | 51 | 0.030 |
Why?
| | Growth Disorders | 1 | 2017 | 87 | 0.030 |
Why?
| | Homozygote | 1 | 2017 | 201 | 0.030 |
Why?
| | Cancellous Bone | 1 | 2016 | 26 | 0.030 |
Why?
| | Dysbiosis | 1 | 2018 | 180 | 0.030 |
Why?
| | Genetic Loci | 1 | 2018 | 277 | 0.030 |
Why?
| | RNA | 1 | 2022 | 930 | 0.030 |
Why?
| | Mice, Congenic | 2 | 2006 | 23 | 0.030 |
Why?
| | Polymerase Chain Reaction | 2 | 2012 | 1056 | 0.030 |
Why?
| | Cryopreservation | 1 | 2016 | 106 | 0.030 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2010 | 761 | 0.030 |
Why?
| | Base Sequence | 2 | 2012 | 2180 | 0.030 |
Why?
| | Age Factors | 2 | 2018 | 3294 | 0.030 |
Why?
| | Regression Analysis | 1 | 2018 | 1023 | 0.030 |
Why?
| | Mice, Mutant Strains | 1 | 2015 | 309 | 0.030 |
Why?
| | Mice, Inbred NZB | 2 | 2006 | 16 | 0.030 |
Why?
| | Wnt Signaling Pathway | 1 | 2017 | 202 | 0.030 |
Why?
| | Disease Progression | 1 | 2022 | 2800 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2020 | 2075 | 0.030 |
Why?
| | Molecular Sequence Data | 2 | 2012 | 2929 | 0.030 |
Why?
| | Tibial Fractures | 1 | 2015 | 69 | 0.030 |
Why?
| | Genes, Reporter | 1 | 2015 | 274 | 0.030 |
Why?
| | Lumbar Vertebrae | 1 | 2016 | 251 | 0.030 |
Why?
| | Exome | 1 | 2015 | 238 | 0.030 |
Why?
| | Epigenesis, Genetic | 1 | 2019 | 663 | 0.030 |
Why?
| | Insulin-Like Growth Factor Binding Proteins | 2 | 2004 | 26 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2017 | 1498 | 0.030 |
Why?
| | Receptor Activator of Nuclear Factor-kappa B | 2 | 2003 | 9 | 0.030 |
Why?
| | Osteoprotegerin | 2 | 2003 | 25 | 0.030 |
Why?
| | RANK Ligand | 2 | 2003 | 29 | 0.030 |
Why?
| | Upper Extremity | 1 | 2014 | 109 | 0.020 |
Why?
| | Fibrosis | 1 | 2015 | 542 | 0.020 |
Why?
| | Biopsy | 1 | 2016 | 1083 | 0.020 |
Why?
| | Receptors, Tumor Necrosis Factor | 2 | 2003 | 166 | 0.020 |
Why?
| | Child | 3 | 2018 | 22414 | 0.020 |
Why?
| | Polymorphism, Restriction Fragment Length | 1 | 2012 | 68 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 346 | 0.020 |
Why?
| | Absorptiometry, Photon | 1 | 2013 | 266 | 0.020 |
Why?
| | Models, Biological | 2 | 2010 | 1828 | 0.020 |
Why?
| | Litter Size | 1 | 2011 | 18 | 0.020 |
Why?
| | Software | 1 | 2016 | 678 | 0.020 |
Why?
| | Tissue Inhibitor of Metalloproteinase-2 | 1 | 2010 | 15 | 0.020 |
Why?
| | Biomechanical Phenomena | 2 | 2004 | 839 | 0.020 |
Why?
| | 3T3-L1 Cells | 1 | 2010 | 37 | 0.020 |
Why?
| | Macrophages | 1 | 2018 | 1562 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2013 | 1275 | 0.020 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2010 | 120 | 0.020 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2010 | 122 | 0.020 |
Why?
| | Lower Extremity | 1 | 2014 | 439 | 0.020 |
Why?
| | Sex Factors | 1 | 2015 | 2063 | 0.020 |
Why?
| | Lipoproteins | 1 | 2010 | 163 | 0.020 |
Why?
| | Risk Factors | 2 | 2016 | 10482 | 0.020 |
Why?
| | Cluster Analysis | 1 | 2010 | 521 | 0.020 |
Why?
| | Chromosomes | 1 | 2009 | 105 | 0.020 |
Why?
| | Biomarkers | 1 | 2020 | 4190 | 0.020 |
Why?
| | Meiosis | 1 | 2009 | 86 | 0.020 |
Why?
| | Bayes Theorem | 1 | 2010 | 418 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2021 | 7923 | 0.020 |
Why?
| | Cell Lineage | 1 | 2010 | 352 | 0.020 |
Why?
| | Insulin-Like Growth Factor Binding Protein 4 | 1 | 2006 | 4 | 0.020 |
Why?
| | Dissection | 1 | 2007 | 55 | 0.020 |
Why?
| | Insulin-Like Growth Factor Binding Protein 2 | 1 | 2006 | 8 | 0.020 |
Why?
| | Insulin-Like Growth Factor II | 1 | 2006 | 22 | 0.020 |
Why?
| | Insulin-Like Growth Factor Binding Protein 3 | 1 | 2006 | 36 | 0.020 |
Why?
| | Receptor, IGF Type 1 | 1 | 2006 | 64 | 0.020 |
Why?
| | Microarray Analysis | 1 | 2006 | 116 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2014 | 2938 | 0.020 |
Why?
| | Genetic Linkage | 1 | 2007 | 288 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2024 | 16374 | 0.020 |
Why?
| | Artificial Intelligence | 1 | 2010 | 337 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2018 | 6289 | 0.020 |
Why?
| | Receptors, Somatotropin | 1 | 2005 | 10 | 0.010 |
Why?
| | Cholesterol | 1 | 2007 | 405 | 0.010 |
Why?
| | Triglycerides | 1 | 2007 | 514 | 0.010 |
Why?
| | Sequence Alignment | 1 | 2005 | 363 | 0.010 |
Why?
| | DNA Primers | 1 | 2006 | 510 | 0.010 |
Why?
| | Drug Administration Schedule | 1 | 2006 | 771 | 0.010 |
Why?
| | Transfection | 1 | 2006 | 943 | 0.010 |
Why?
| | Down-Regulation | 1 | 2006 | 641 | 0.010 |
Why?
| | Stress, Mechanical | 1 | 2006 | 489 | 0.010 |
Why?
| | Alkaline Phosphatase | 1 | 2004 | 149 | 0.010 |
Why?
| | Brain | 1 | 2016 | 2868 | 0.010 |
Why?
| | Radiography | 1 | 2006 | 844 | 0.010 |
Why?
| | Nitric Oxide Donors | 1 | 2003 | 21 | 0.010 |
Why?
| | Guanylate Cyclase | 1 | 2003 | 38 | 0.010 |
Why?
| | Nitroprusside | 1 | 2003 | 72 | 0.010 |
Why?
| | Cyclic GMP | 1 | 2003 | 91 | 0.010 |
Why?
| | Infant | 1 | 2018 | 9843 | 0.010 |
Why?
| | Calcitriol | 1 | 2003 | 59 | 0.010 |
Why?
| | Blotting, Western | 1 | 2006 | 1234 | 0.010 |
Why?
| | Parathyroid Hormone | 1 | 2003 | 111 | 0.010 |
Why?
| | Algorithms | 1 | 2010 | 1768 | 0.010 |
Why?
| | Child, Preschool | 1 | 2018 | 11512 | 0.010 |
Why?
| | Recombination, Genetic | 1 | 2003 | 206 | 0.010 |
Why?
| | Human Growth Hormone | 1 | 2002 | 48 | 0.010 |
Why?
| | Phylogeny | 1 | 2006 | 1019 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2006 | 1739 | 0.010 |
Why?
| | Pregnancy | 1 | 2014 | 7092 | 0.010 |
Why?
| | Tibia | 1 | 2002 | 183 | 0.010 |
Why?
| | Enzyme Inhibitors | 1 | 2003 | 855 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2002 | 1363 | 0.010 |
Why?
| | Kinetics | 1 | 2002 | 1655 | 0.010 |
Why?
| | NF-kappa B | 1 | 2002 | 692 | 0.010 |
Why?
| | Adolescent | 1 | 2018 | 22130 | 0.010 |
Why?
| | Young Adult | 1 | 2014 | 13749 | 0.010 |
Why?
| | Signal Transduction | 1 | 2006 | 5169 | 0.010 |
Why?
|
|
Ackert-Bicknell's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|